64 related articles for article (PubMed ID: 10037189)
1. Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.
Perkins MS; Louw-du Toit R; Jackson H; Simons M; Africander D
Front Endocrinol (Lausanne); 2022; 13():959396. PubMed ID: 36187129
[TBL] [Abstract][Full Text] [Related]
2. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection.
Singh M; Krishnamoorthy VR; Kim S; Khurana S; LaPorte HM
Front Endocrinol (Lausanne); 2024; 15():1286066. PubMed ID: 38469139
[TBL] [Abstract][Full Text] [Related]
4. High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin.
Bajalovic N; Or YZ; Woo ARE; Lee SH; Lin VCL
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009407
[TBL] [Abstract][Full Text] [Related]
5. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
7. Tetratricopeptide repeat domain 9A modulates anxiety-like behavior in female mice.
Lim LW; Shrestha S; Or YZ; Tan SZ; Chung HH; Sun Y; Lim CL; Khairuddin S; Lufkin T; Lin VC
Sci Rep; 2016 Nov; 6():37568. PubMed ID: 27869229
[TBL] [Abstract][Full Text] [Related]
8. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.
McFall T; Patki M; Rosati R; Ratnam M
Oncotarget; 2015 Oct; 6(32):33146-64. PubMed ID: 26356672
[TBL] [Abstract][Full Text] [Related]
9. Tetratricopeptide repeat domain 9A negatively regulates estrogen receptor alpha activity.
Shrestha S; Sun Y; Lufkin T; Kraus P; Or Y; Garcia YA; Guy N; Ramos P; Cox MB; Tay F; Lin VC
Int J Biol Sci; 2015; 11(4):434-47. PubMed ID: 25798063
[TBL] [Abstract][Full Text] [Related]
10. Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor.
Chung HH; Sze SK; Woo AR; Sun Y; Sim KH; Dong XM; Lin VC
J Biol Chem; 2014 Feb; 289(9):5704-22. PubMed ID: 24415758
[TBL] [Abstract][Full Text] [Related]
11. Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.
Chung HH; Sze SK; Tay AS; Lin VC
J Biol Chem; 2014 Jan; 289(4):2180-94. PubMed ID: 24302725
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
[TBL] [Abstract][Full Text] [Related]
13. Progestin modulates the lipid profile and sensitivity of breast cancer cells to docetaxel.
Schlaepfer IR; Hitz CA; Gijón MA; Bergman BC; Eckel RH; Jacobsen BM
Mol Cell Endocrinol; 2012 Nov; 363(1-2):111-21. PubMed ID: 22922095
[TBL] [Abstract][Full Text] [Related]
14. p38 and p42/44 MAPKs differentially regulate progesterone receptor A and B isoform stabilization.
Khan JA; Amazit L; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
Mol Endocrinol; 2011 Oct; 25(10):1710-24. PubMed ID: 21816898
[TBL] [Abstract][Full Text] [Related]
15. Progesterone induces cellular differentiation in MDA-MB-231 breast cancer cells transfected with progesterone receptor complementary DNA.
Lin VC; Jin R; Tan PH; Aw SE; Woon CT; Bay BH
Am J Pathol; 2003 Jun; 162(6):1781-7. PubMed ID: 12759236
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
Jin R; Bay BH; Chow VT; Tan PH; Lin VC
Br J Cancer; 2000 Aug; 83(3):319-23. PubMed ID: 10917545
[TBL] [Abstract][Full Text] [Related]
17. Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA.
Lin VC; Ng EH; Aw SE; Tan MG; Ng EH; Chan VS; Ho GH
Clin Cancer Res; 1999 Feb; 5(2):395-403. PubMed ID: 10037189
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
